Sterling Capital Management LLC Has $2.87 Million Stock Position in Cencora, Inc. $COR

Sterling Capital Management LLC lowered its position in Cencora, Inc. (NYSE:COR) by 64.2% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 9,136 shares of the company’s stock after selling 16,394 shares during the quarter. Sterling Capital Management LLC’s holdings in Cencora were worth $2,870,000 as of its most recent SEC filing.

Other institutional investors also recently modified their holdings of the company. T. Rowe Price Investment Management Inc. lifted its position in Cencora by 160.1% in the fourth quarter. T. Rowe Price Investment Management Inc. now owns 6,700,091 shares of the company’s stock worth $2,262,956,000 after purchasing an additional 4,123,795 shares during the period. Norges Bank acquired a new position in shares of Cencora in the 4th quarter valued at $822,506,000. Marshall Wace LLP lifted its holdings in shares of Cencora by 518.9% during the 3rd quarter. Marshall Wace LLP now owns 1,995,118 shares of the company’s stock worth $623,534,000 after acquiring an additional 1,672,762 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its position in shares of Cencora by 528.9% during the 3rd quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 1,475,859 shares of the company’s stock valued at $461,250,000 after acquiring an additional 1,241,186 shares in the last quarter. Finally, Viking Global Investors LP boosted its position in shares of Cencora by 95.0% during the 2nd quarter. Viking Global Investors LP now owns 2,081,732 shares of the company’s stock valued at $624,207,000 after acquiring an additional 1,013,913 shares in the last quarter. Institutional investors and hedge funds own 97.52% of the company’s stock.

Insider Transactions at Cencora

In related news, Director Lauren M. Tyler acquired 550 shares of the firm’s stock in a transaction on Monday, June 22nd. The shares were purchased at an average price of $270.23 per share, with a total value of $148,626.50. Following the acquisition, the director directly owned 4,359 shares in the company, valued at $1,177,932.57. The trade was a 14.44% increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is available through this link. 0.38% of the stock is currently owned by company insiders.

Cencora Stock Performance

NYSE COR opened at $286.97 on Monday. Cencora, Inc. has a 1-year low of $244.82 and a 1-year high of $377.54. The company has a 50 day moving average of $280.84 and a 200-day moving average of $322.07. The company has a current ratio of 0.95, a quick ratio of 0.59 and a debt-to-equity ratio of 3.40. The firm has a market cap of $55.83 billion, a price-to-earnings ratio of 22.01, a PEG ratio of 1.59 and a beta of 0.59.

Cencora (NYSE:COR) last released its quarterly earnings results on Wednesday, May 6th. The company reported $4.75 EPS for the quarter, missing analysts’ consensus estimates of $4.82 by ($0.07). Cencora had a return on equity of 135.20% and a net margin of 0.78%.The business had revenue of $78.36 billion for the quarter, compared to the consensus estimate of $81.09 billion. During the same quarter last year, the company earned $4.42 earnings per share. The firm’s revenue was up 3.9% on a year-over-year basis. Cencora has set its FY 2026 guidance at 17.650-17.900 EPS. On average, equities analysts forecast that Cencora, Inc. will post 17.79 earnings per share for the current fiscal year.

Cencora declared that its board has initiated a stock repurchase program on Thursday, May 21st that permits the company to buyback $2.00 billion in outstanding shares. This buyback authorization permits the company to buy up to 3.9% of its shares through open market purchases. Shares buyback programs are often an indication that the company’s board believes its shares are undervalued.

Cencora Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Monday, June 1st. Investors of record on Friday, May 15th were issued a $0.60 dividend. This represents a $2.40 dividend on an annualized basis and a dividend yield of 0.8%. The ex-dividend date of this dividend was Friday, May 15th. Cencora’s payout ratio is currently 18.40%.

Wall Street Analysts Forecast Growth

COR has been the subject of several recent research reports. Morgan Stanley set a $342.00 price target on shares of Cencora in a research report on Friday, May 8th. Evercore set a $360.00 price objective on Cencora in a research note on Wednesday, April 8th. Bank of America increased their target price on Cencora from $280.00 to $285.00 and gave the stock a “neutral” rating in a report on Wednesday, June 24th. Leerink Partners restated an “outperform” rating on shares of Cencora in a research report on Tuesday, March 17th. Finally, Wells Fargo & Company decreased their price target on Cencora from $429.00 to $331.00 and set an “overweight” rating on the stock in a research note on Monday, May 11th. Twelve analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. According to data from MarketBeat, Cencora has a consensus rating of “Moderate Buy” and a consensus price target of $367.75.

About Cencora

Cencora (NYSE:COR) is a global healthcare services and pharmaceutical distribution company that provides end-to-end solutions across the pharmaceutical supply chain. The company’s core activities include wholesale drug distribution, specialty drug distribution, and the operation of specialty pharmacies, complemented by logistics, cold-chain management and other fulfillment services designed to support complex and temperature-sensitive therapies.

Beyond physical distribution, Cencora offers a range of commercial and patient-focused services for pharmaceutical manufacturers and healthcare providers.